Evaxion Biotech Q3 EPS $(0.01), Inline
Benzinga Newsdesk 2 days ago
NewsEarnings
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is a 200 percent decrease over earnings of $0.01 per share from the same period last year.
Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is a 200 percent decrease over earnings of $0.01 per share from the same period last year.
